Drug Information

Drug General Information
Drug ID
D02YEG
Former ID
DIB006170
Drug Name
VBY-376
Synonyms
Protease inhibitor (hepatitis C virus infection), Virobay
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Phase 1 [522157]
Company
Virobay Inc
Target and Pathway
Target(s) Nonstructural protein NS3 Target Info Inhibitor [544195]
References
Ref 522157ClinicalTrials.gov (NCT00557583) Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults. U.S. National Institutes of Health.
Ref 544195Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the Tunnel. Viruses. 2010 August; 2(8): 1752-1765.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.